BALCHEM ($BCPC) posted quarterly earnings results on Thursday, April 24th. The company reported earnings of $1.22 per share, missing estimates of $1.27 by $0.05. The company also reported revenue of $250,520,000, beating estimates of $249,592,980 by $927,020.
You can see Quiver Quantitative's $BCPC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BALCHEM Hedge Fund Activity
We have seen 177 institutional investors add shares of BALCHEM stock to their portfolio, and 137 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- APG ASSET MANAGEMENT N.V. removed 822,904 shares (-29.7%) from their portfolio in Q4 2024, for an estimated $134,129,237
- BLACKROCK, INC. added 196,865 shares (+4.0%) to their portfolio in Q4 2024, for an estimated $32,088,010
- WASATCH ADVISORS LP removed 152,764 shares (-11.3%) from their portfolio in Q4 2024, for an estimated $24,899,768
- PROFICIO CAPITAL PARTNERS LLC added 144,956 shares (+inf%) to their portfolio in Q4 2024, for an estimated $23,627,103
- BANK OF AMERICA CORP /DE/ added 85,692 shares (+120.9%) to their portfolio in Q4 2024, for an estimated $13,967,367
- FMR LLC added 79,499 shares (+16.0%) to their portfolio in Q4 2024, for an estimated $12,957,939
- BNP PARIBAS FINANCIAL MARKETS added 60,449 shares (+283.1%) to their portfolio in Q4 2024, for an estimated $9,852,884
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
